Profil
Ms. Kelly E.
Lisbakken is a Managing Director at Wedbush Securities, Inc.
Ms. Lisbakken joined Pacific Growth Equities in 2004 and has completed over 300 transactions with the firm raising over $36 billion.
Prior to Wedbush, she worked at ICOS (now part of Eli Lilly) on Cialis and the PDE4 program.
She holds an AB in Molecular Biology from Princeton University.
Postes actifs de Kelly Elizabeth Lisbakken
| Sociétés | Poste | Début |
|---|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Analyst-Equity | 01/03/2009 |
Anciens postes connus de Kelly Elizabeth Lisbakken
| Sociétés | Poste | Fin |
|---|---|---|
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Directeur/Membre du Conseil | 31/01/2025 |
Formation de Kelly Elizabeth Lisbakken
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
















